CVS GroupLSE:CVSG +0.68%89 Net Margin % is 2.19% as of Dec. 2025, which is 38% below its 10-year median of 3.53. GuruFocus rates LSE:CVSG with a GF Score™ of 89/100 and a GF Value™ of £13.43 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, CVS Group ranks better than 69.46% on this metric.
Net margin is calculated as Net Income divided by its Revenue. CVS Group's Net Income for the
six
months ended in Dec. 2025 was £7.8 Mil. CVS Group's Revenue for the
six
months ended in Dec. 2025 was £356.9 Mil. Therefore, CVS Group's net margin for the quarter that ended in Dec. 2025 was 2.19%.
The historical rank and industry rank for CVS Group's Net Margin % or its related term are showing as below:
LSE:CVSG'
s Net Margin % Range Over the Past 10 Years
Min: 1 Med: 3.53 Max: 7.87
Current: 7.16
LSE:CVSG's Net Margin % is ranked better than 69.46% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs LSE:CVSG: 7.16
CVS Group (LSE:CVSG) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
CVS Group Net Margin % Related Terms
CVS Group Net Margin % Historical Data
* Premium members only.
The historical data trend for CVS Group's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:CVSG vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, CVS Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's Net Margin % distribution charts can be found below:
* The bar in red indicates where CVS Group's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVS Group (LSE:CVSG) has a Net Margin % of 2.19% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on CVS Group and its competitors. This is 38% below median its historical median of 3.53. Over the past decade, CVS Group's Net Margin % has ranged from 1.00 to 7.87. According to the industry distribution chart, CVS Group ranks #204 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 30.5%.
Is CVS Group's Net Margin % too high?
CVS Group's current Net Margin % of 2.19% is 38% below median its 10-year median of 3.53. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.87. The Healthcare Providers & Services industry median Net Margin % is 2.89. CVS Group's value of 2.19% is 24.1% below this industry median. Based on the distribution chart, CVS Group ranks #204 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CVS Group has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #204 out of 668 companies for Net Margin %. This puts CVS Group in the upper half of its industry. The industry median Net Margin % is 2.89. CVS Group's value of 2.19% is 24.1% below this benchmark. Historically, CVS Group's own Net Margin % has ranged from 1.00 to 7.87 over the past decade. While the company's 10-year median is 3.53 vs. the industry median of 2.89, CVS Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current Net Margin % of 2.19% is 24.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on CVS Group and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current Net Margin % is 2.19%, which is 38% below median its own 10-year median of 3.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (LSE:CVSG) is currently considered Modestly Undervalued. The stock's GF Value™ is £13.43, compared to a current price of £11.81 — trading 12.1% below its estimated fair value. The current Net Margin % is 2.19%, which is 38% below median its 10-year median of 3.53 and 24.1% below the Healthcare Providers & Services industry median of 2.89. CVS Group's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For CVS Group (LSE:CVSG), the current Net Margin % is 2.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (LSE:CVSG) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of £11.81 is trading 12.1% below its estimated GF Value™ of £13.43.
GuruFocus considers CVS Group to be Modestly Undervalued.
Key valuation signals for LSE:CVSG:
Net Margin %: 2.19% (38% below median its 10-year median of 3.53)
GF Value™: £13.43 vs. price of £11.81 (12.1% below fair value)
Industry Position: 24.1% below the Healthcare Providers & Services median (#204 of 668)
No single metric tells the full story. See the LSE:CVSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
89GF Score
Get the complete analysis for LSE:CVSG
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CVSG has been successfully added to your 
